Enway Pharmaceuticals announced that recently, the company learned that 137,584 shares of the controlling shareholder Enwei Group, which had previously been judicially frozen, have been unfrozen, accounting for 0.53% of its shares and 0.13% of the company's total share capital. The release date is July 16, 2026. As of the date of disclosure of the announcement, the cumulative number of shares held by controlling shareholders and their co-actors had been frozen was 0. The lifting of the stock freeze will not lead to a change in the company's control, and there will be no significant adverse impact on the company's production and operation.

Enway Pharmaceuticals announced that recently, the company learned that 137,584 shares of the controlling shareholder Enwei Group, which had previously been judicially frozen, have been unfrozen, accounting for 0.53% of its shares and 0.13% of the company's total share capital. The release date is July 16, 2026. As of the date of disclosure of the announcement, the cumulative number of shares held by controlling shareholders and their co-actors had been frozen was 0. The lifting of the stock freeze will not lead to a change in the company's control, and there will be no significant adverse impact on the company's production and operation.